Tepezza

Active Ingredient(s): Teprotumumab-trbw
FDA Approved: * January 21, 2020
Pharm Company: * HORIZON THERAPEUTICS IRELAND
Category: Vision / Eye Health

Teprotumumab, sold under the brand name Tepezza, is a medication used to treat adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to bulge outwards.[1] The most common side effects are muscle spasm, nausea, hair loss, diarrhea, fatigue, high blood sugar, hearing loss, dry skin, altered sense of taste and headache.[1] Teprotumumab should not be used if pregnant, and women of chil... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tepezza 500 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 75987-130
Labeler:
Horizon Therapeutics USA, Inc.